KOSÉ (4922) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for 1H/2Q 2024 rose 10.3% year-over-year to ¥159.1 billion, driven by strong performance in Japan and Tarte, offsetting declines in China.
Operating profit increased 31.9% year-over-year to ¥13.7 billion, with an operating margin of 8.6%.
Net income attributable to owners of parent grew 33.5% year-over-year, aided by foreign exchange gains.
Overseas sales accounted for 36.4% of total sales; Japan and North America saw significant gains while China declined.
Comprehensive income increased 44.7% to ¥17,617 million.
Financial highlights
Gross profit rose 9.1% year-over-year to ¥112.6 billion; SG&A expenses increased 6.6% but the ratio to sales decreased.
Net income per share was ¥203.47, up ¥51.03 from the prior year.
Total assets reached ¥380.1 billion with an equity ratio above 70%.
Cash and cash equivalents decreased by ¥6.3 billion, but liquidity remains sound.
Comprehensive income increased 44.7% to ¥17,617 million.
Outlook and guidance
2024 full-year net sales forecast maintained at ¥312.0 billion (+3.9% YoY); operating profit projected at ¥20.0 billion (+25.1% YoY).
No revision to overall 2024 outlook, but regional and segment breakdowns adjusted to reflect 1H results and forex impacts.
Second half sales growth expected to moderate due to prior year recovery; no V-shaped recovery anticipated in China.
Full-year dividend forecast unchanged at ¥140 per share; interim dividend of ¥70 per share paid.
Net income forecast for 2024 is ¥12.6 billion, EPS ¥220.83.
Latest events from KOSÉ
- FY2025 delivered higher sales and profit, with FY2026 targeting further growth but lower net income.4922
Q4 202512 Feb 2026 - Sales up slightly, but profit down on higher costs and FX losses; full-year outlook maintained.4922
Q3 202510 Nov 2025 - Operating profit fell 17.7% as higher costs and FX losses offset modest sales growth.4922
Q2 20257 Aug 2025 - Sales growth offset by China restructuring loss; profit outlook cut, dividend steady.4922
Q3 202413 Jun 2025 - Sales up, profits down; 2025 outlook positive despite cost and FX headwinds.4922
Q1 20256 Jun 2025 - 2024 profit fell on China reforms, but 2025 outlook is for strong recovery and sales growth.4922
Q4 20246 Jun 2025